×
It looks like you're using an obsolete version of internet explorer. Internet explorer is no longer supported by Microsoft since the end of 2015. We invite you to use a newer browser such as Firefox, Google Chrome or Microsoft Edge.

Become an Oncostream member and receive full access to its content!

You must be an Oncostream member to access videos without any restrictions. Register for free in one minute and access all services provided by Oncostream.You will also be able to log into Oncostream from your Facebook or twitter account by clicking on login on the top-right corner of Oncostream website.

Registration Login


Worldwide schedules comment Share

Modératrice :
Isabelle Ray-Coquard

Intervenants :
Florence Joly
Olivia Le Saux
Stanislas Quesada

Agenda

18:00 Caractérisation et définition de la rechute et de la résistance aux sels de platine
Olivia Le Saux
 
18:20 Stratégie thérapeutique actuelle et à venir (incluant les nouveaux biomarqueurs dans les cancers de l'ovaire en rechute)
Stanislas Quesada
 
18:40 Quelles spécificités du parcours de soins des cancers résistants aux sels de platine
Florence Joly
 
19:00 Débat/Discussion – Réponses aux questions
 

 

Shooting date : 2025-01-22
Last update : 2025-01-28

Suggestions

Tuesday, December 13th 2022 from 06pm to 07:30pm (GMT+1)
Honolulu : Tuesday, December 13th 2022 from 06am to 07:30am (GMT+1)
San Francisco : Tuesday, December 13th 2022 from 08am to 09:30am (GMT+1)
New York : Tuesday, December 13th 2022 from 11am to 12:30pm (GMT+1)
Buenos Aires : Tuesday, December 13th 2022 from 01pm to 02:30pm (GMT+1)
London / Dublin : Tuesday, December 13th 2022 from 04pm to 05:30pm (GMT+1)
Paris / Berlin : Tuesday, December 13th 2022 from 05pm to 06:30pm (GMT+1)
Istanbul : Tuesday, December 13th 2022 from 06pm to 07:30pm (GMT+1)
Moscou / Dubaï : Tuesday, December 13th 2022 from 08pm to 09:30pm (GMT+1)
Bangkok : Tuesday, December 13th 2022 from 11pm to 12:30am (GMT+1)
Shanghai : Wednesday, December 14th 2022 from 12am to 01:30am (GMT+1)
Tokyo : Wednesday, December 14th 2022 from 01am to 02:30am (GMT+1)
Sydney : Wednesday, December 14th 2022 from 02am to 03:30am (GMT+1)
Wellington : Wednesday, December 14th 2022 from 04am to 05:30am (GMT+1)

Last improvements in advanced ovarian cancer treatment

Trials that have or will impact practices in the management of patients with advanced ovarian cancer

Share
Wednesday, November 16th 2022 from 06pm to 07:30pm (GMT+1)
Honolulu : Wednesday, November 16th 2022 from 06am to 07:30am (GMT+1)
San Francisco : Wednesday, November 16th 2022 from 08am to 09:30am (GMT+1)
New York : Wednesday, November 16th 2022 from 11am to 12:30pm (GMT+1)
Buenos Aires : Wednesday, November 16th 2022 from 01pm to 02:30pm (GMT+1)
London / Dublin : Wednesday, November 16th 2022 from 04pm to 05:30pm (GMT+1)
Paris / Berlin : Wednesday, November 16th 2022 from 05pm to 06:30pm (GMT+1)
Istanbul : Wednesday, November 16th 2022 from 06pm to 07:30pm (GMT+1)
Moscou / Dubaï : Wednesday, November 16th 2022 from 08pm to 09:30pm (GMT+1)
Bangkok : Wednesday, November 16th 2022 from 11pm to 12:30am (GMT+1)
Shanghai : Thursday, November 17th 2022 from 12am to 01:30am (GMT+1)
Tokyo : Thursday, November 17th 2022 from 01am to 02:30am (GMT+1)
Sydney : Thursday, November 17th 2022 from 02am to 03:30am (GMT+1)
Wellington : Thursday, November 17th 2022 from 04am to 05:30am (GMT+1)

Cancer de l’ovaire et iPARP

Share
Tuesday, November 21st 2023 from 06pm to 07:30pm (GMT+1)
Honolulu : Tuesday, November 21st 2023 from 06am to 07:30am (GMT+1)
San Francisco : Tuesday, November 21st 2023 from 08am to 09:30am (GMT+1)
New York : Tuesday, November 21st 2023 from 11am to 12:30pm (GMT+1)
Buenos Aires : Tuesday, November 21st 2023 from 01pm to 02:30pm (GMT+1)
London / Dublin : Tuesday, November 21st 2023 from 04pm to 05:30pm (GMT+1)
Paris / Berlin : Tuesday, November 21st 2023 from 05pm to 06:30pm (GMT+1)
Istanbul : Tuesday, November 21st 2023 from 06pm to 07:30pm (GMT+1)
Moscou / Dubaï : Tuesday, November 21st 2023 from 08pm to 09:30pm (GMT+1)
Bangkok : Tuesday, November 21st 2023 from 11pm to 12:30am (GMT+1)
Shanghai : Wednesday, November 22nd 2023 from 12am to 01:30am (GMT+1)
Tokyo : Wednesday, November 22nd 2023 from 01am to 02:30am (GMT+1)
Sydney : Wednesday, November 22nd 2023 from 02am to 03:30am (GMT+1)
Wellington : Wednesday, November 22nd 2023 from 04am to 05:30am (GMT+1)

Cancer de l'ovaire : comment évaluer aujourd'hui la recombinaison homologue ?

Share
Wednesday, February 7th 2024 from 06pm to 07:30pm (GMT+1)
Honolulu : Wednesday, February 7th 2024 from 06am to 07:30am (GMT+1)
San Francisco : Wednesday, February 7th 2024 from 08am to 09:30am (GMT+1)
New York : Wednesday, February 7th 2024 from 11am to 12:30pm (GMT+1)
Buenos Aires : Wednesday, February 7th 2024 from 01pm to 02:30pm (GMT+1)
London / Dublin : Wednesday, February 7th 2024 from 04pm to 05:30pm (GMT+1)
Paris / Berlin : Wednesday, February 7th 2024 from 05pm to 06:30pm (GMT+1)
Istanbul : Wednesday, February 7th 2024 from 06pm to 07:30pm (GMT+1)
Moscou / Dubaï : Wednesday, February 7th 2024 from 08pm to 09:30pm (GMT+1)
Bangkok : Wednesday, February 7th 2024 from 11pm to 12:30am (GMT+1)
Shanghai : Thursday, February 8th 2024 from 12am to 01:30am (GMT+1)
Tokyo : Thursday, February 8th 2024 from 01am to 02:30am (GMT+1)
Sydney : Thursday, February 8th 2024 from 02am to 03:30am (GMT+1)
Wellington : Thursday, February 8th 2024 from 04am to 05:30am (GMT+1)

Toxicités hématologiques des inhibiteurs de PARP

Regards croisés oncologue-hématologue-interniste

Share
Scroll Up